Vertex Pharmaceuticals Stock Soaring: Is More Upside Ahead?
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
Explore the debate of cash back vs. points to determine which rewards suit your spending habits best. Make informed choices for your finances.
26,869 articlesVertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
Today’s stock market activity shows SoFi (SOFI) directing attention as investors weigh inflation signals and higher y...
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
A growth stock has fallen over 40% in 2026, testing the patience of investors. This guide breaks down how to assess w...
Team (TISI) kicks off 2025 with a solid Q1 showing that blends growing customer demand with margin challenges. This a...
Auto-investing can grow wealth, but it only works if you actively monitor it. This guide shows how to spot drift, tam...
AST SpaceMobile faces a pivotal Q4 2025 print after the bell on March 2, 2026, with analysts eyeing a revenue uptick ...
When a century-spanning blue-chip changes its share count, investors take notice. This article breaks down what a rev...
Investing in a high-flying name like SpaceX can spark excitement. This article breaks down two strong reasons to wait...
May could mark a turning point for investors eyeing the clean energy revival. This article breaks down two nuclear en...
As the Great Migration accelerates, Vanguard’s Value ETF is leading a rotation into cash-generative stocks, signaling...
Congress weighs eliminations real estate tax breaks, and the ripple effects could touch every landlord's bottom line....